(19)
(11) EP 4 680 288 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24720358.1

(22) Date of filing: 16.03.2024
(51) International Patent Classification (IPC): 
A61K 49/00(2006.01)
A61K 39/395(2006.01)
C07K 16/18(2006.01)
A61P 25/28(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 49/0008; C07K 16/18; A61P 25/28; A01K 2207/15; A01K 2217/052; A01K 2267/0312; A01K 2207/10; G01N 33/6896; A61K 2039/505
(86) International application number:
PCT/US2024/020329
(87) International publication number:
WO 2024/192429 (19.09.2024 Gazette 2024/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 16.03.2023 US 202363490715 P

(71) Applicant: Abbvie Inc.
North Chicago, Illinois 60064 (US)

(72) Inventor:
  • SMITH, Tammy, D.
    Carlisle, Massachusetts 01741 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) ASSAY FOR EVALUATING TAU PROPAGATION